Study finds ACA slowed rise in employer-sponsored premiums
A new Commonwealth Fund study finds that, following implementation of the Affordable Care Act, premiums for employer-sponsored insurance in 31 states grew more slowly than in previous years.
A new Commonwealth Fund study finds that, following implementation of the Affordable Care Act (ACA), premiums for employer-sponsored insurance in 31 states grew more slowly than in previous years.
But more costs were also shifted to employees in the form of premiums and deductibles, and by 2013, premium costs ate up more than 20% of income in 37 states, according to the study.
Premium increases from 2010 to 2013 grew three times faster than income, while per-person deductibles at least doubled in all but six states and the District of Columbia.
p
Noting that premiums in the ACA’s federal marketplace were also slower than expected, the study says the main reason for the slowdown in premium growth is a decline in healthcare spending since 2009.
Based on an analysis of claims data, the study found that families and employees had used fewer services between 2009 and 2014, including hospital care and elective surgery.
Quality initiates implemented as a part of the ACA, including alterative models of care delivery and efforts to reduce waste and duplication, might also be contributing to the slowdown in premium growth, notes the study.
Optimizing narcolepsy care: Diagnosis, treatment and patient access | Written recap
April 4th 2025In a recent Managed Healthcare Executive K-Cast video series, R. Robert Auger, M.D., a psychiatrist and sleep specialist at the Mayo Clinic in Rochester, Minnesota, spoke about the diagnosis and treatment of narcolepsy and idiopathic hypersomnia. This is a written recap of that series.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Exploring the Wide World of GLP-1s | AMCP Annual 2025
April 3rd 2025Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their effects on various other conditions, such as sleep apnea, substance use disorder and Alzheimer’s disease, according to panelists participating in a keynote session of the Academy of Managed Care Pharmacy annual meeting today in Houston.
Read More
